China Digest: China Resources Biopharmaceutical, ASTSiC, Qiyu snap funds

China Digest: China Resources Biopharmaceutical, ASTSiC, Qiyu snap funds

A researcher at Shanghai UniXell Biotechnology is observing the growth condition of pluripotent stem cells under a microscope. Source: Shanghai UniXell Biotechnology

China Resources Biopharmaceutical has raised $89 million, semiconductor firm ASTSiC has bagged almost $45 million, while Qiyu, incubated by the Chinese video streaming platform iQIYI, has secured over $59m, according to a report.  

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter